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Background: Despite the high prevalence of peripheral arterial disease (PAD) in women, risk factors for PAD in women
are not well understood.
Methods: Gender-speciﬁc risk factors for PAD were examined in a prospective cohort study of 1024 patients (184 women
and 840 men) with stable coronary artery disease who were recruited between 2000 and 2002. Logistic regression models
were used to evaluate associations between traditional and nontraditional risk factors and PAD in men and women.
Results: PAD was found in 11% of women and in 13% of men. Women with PAD had a similar prevalence of traditional
risk factors (hypertension, hyperlipidemia, and smoking) compared with women without PAD and were signiﬁcantly
more likely to suffer from depression than women without PAD. Men with PAD were more likely to have hypertension,
diabetes mellitus, a history of smoking, a worse lipid proﬁle, and higher levels of inﬂammatory biomarkers than men
without PAD. A multivariate model showed depression was the strongest independent factor associated with PAD in
women, whereas smoking and elevated ﬁbrinogen were independently associated with PAD in men.
Conclusions: The current ﬁndings suggest there are gender differences in risk factors for the development of PAD. Further
research is needed to understand the role of depression in PAD. (J Vasc Surg 2014;60:396-403.)Peripheral arterial disease (PAD) is a signiﬁcant cause
of morbidity and mortality and has recently been recog-
nized as a global pandemic.1 PAD is under-recognized
and under-treated in women, even though there appears
to be an increasing population burden of PAD in
women.2,3 In fact, in the 2010 United States Census, the
prevalence of PAD was higher in women than in men.4
Despite the high prevalence of PAD in women, women
are under-represented in contemporary PAD studies,5,6
and risk factors for PAD in women have not been exten-
sively studied. In view of this, the American Heart Associ-
ation issued a scientiﬁc statement calling for further
research to study PAD in women.4
Traditional cardiovascular disease (CVD) risk factors
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with men is well known, and we recently demonstrated
that depression was a strong and independent risk factor
for PAD.12 Others have shown that among patients with
PAD, those with depression have worse functional out-
comes, greater need for revascularization, and have poorer
quality of life outcomes and a higher risk for adverse events
after revascularization.13-16 Research has also indicated that
women with PAD aged <65 years are particularly vulnerable
to experiencing depressive symptoms and that these symp-
toms seem to be accompanied with high rates of smoking.17
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might identify risk factors that can be addressed to mitigate
patients’ depressive symptoms and their cardiovascular risk.
The Heart and Soul Study was designed to study the asso-
ciation between psychologic disorders and cardiovascular
events, including PAD, in outpatients with stable coronary
artery disease (CAD). In this study, we investigated the
gender-speciﬁc prevalence of traditional CVD, psychologic,
and social risk factors for PAD. We hypothesized that
women with PAD would have a different risk factor proﬁle,
including psychosocial factors, compared with men with
PAD.
METHODS
Study population. The Heart and Soul Study was
designed to study the association between psychologic dis-
orders and cardiovascular events in outpatients with stable
CAD. Detailed methods have been previously described.18
Brieﬂy, the investigators performed a prospective cohort
study of 1024 subjects with known coronary heart disease
(CHD) who were recruited between 2000 and 2002 and
followed up for 10 years.
At the baseline examination, participants completed a
structured diagnostic interview for depression, an extensive
questionnaire, electrocardiogram, 6-minute walk test, and
full exercise treadmill testing with stress echocardiography.
Participants were instructed to bring their medication bot-
tles to the study appointment, and study personnel recorded
all current medications. Participants also completed 24-hour
ambulatory Holter monitoring to determine heart rate vari-
ability and collected 24-hour urine for measurement of
creatinine, free cortisol, and catecholamines. Fasting blood
was drawn, and samples of serum, plasma, DNA, and
24-hour urine were stored in a specimen biorepository
at 80C.
After 5 years of follow-up, 667 participants (>80% of
survivors) completed a repeat examination that included a
structured diagnostic interview for depression, question-
naire, electrocardiogram, exercise treadmill test, fasting
blood draw, and 24-hour urine collection. Participants
were also contacted annually to inquire about cardiovascu-
lar events, which were conﬁrmed by review of medical re-
cords. Follow-up information was available for >99% of
the study participants.
With regards to inclusion criteria, the investigators
used administrative databases to identify outpatients with
documented CAD at two Department of Veterans Affairs
Medical Centers (San Francisco VA Medical Center and
the VA Palo Alto Health Care System), one university
medical center (University of California, San Francisco),
and nine public health clinics in the Community Health
Network of San Francisco. Patients were eligible to partic-
ipate if they had known CHD documented by at least one
of the following: a history of myocardial infarction (MI),
angiographic evidence of at least 50% stenosis in one
or more coronary vessels, prior evidence of inducible
ischemia by treadmill or nuclear testing, or a history of cor-
onary revascularization.Related to exclusion criteria, 15,438 patients with
CHD were identiﬁed from administrative databases and
mailed an invitation to participate. Of the 2495 patients
who returned a form indicating that they would be inter-
ested in participating, 505 could not be reached by tele-
phone, and 370 were excluded because they had a
history of MI in the prior 6 months (treadmill test contra-
indicated), deemed themselves unable to walk 1 block
(treadmill test not useful), or were planning to move out
of the local area within 2 years (unavailable for follow-
up). Of the 1620 patients who were conﬁrmed eligible,
596 declined to participate, and 1024 (63%) enrolled.
Between September 11, 2000, and December 20,
2002, 1024 participants were enrolled and were followed
up for a mean 7.2 6 2.6 (standard deviation) years. Of
those, 134 were found to have PAD (21 women and 113
men), deﬁned by self-report of this diagnosis on entering
the study in 84 (men, 8%; women, 9%); by diagnosis by a
physician during hospitalization in 56 (men, 6%; women,
4%); by ultrasound imaging or angiographically demon-
strated obstruction or ulcerated plaque (>50% of diameter
or >75% of x-sectional area) of the iliac arteries or below in
40 (men, 4%; women, 3%); by surgery, angioplasty, or
thrombolysis for PAD in 40 (men, 4%; women, 2%); or
by exertional leg pain relieved by rest in 23 (men, 2%;
women, 2%).
Study measurements. All participants completed a
baseline examination that included an interview, fasting
venous blood sample collection, a standardized medical
history questionnaire, echocardiography, exercise treadmill
testing, 24-hour ambulatory Holter monitoring, and a 24-
hour urine collection. Age, sex, race, education level, and
medical history were determined by self-report question-
naire. Height and weight were measured by a standardized
protocol, with body mass index calculated as weight (kg)/
height (m2). Participants were instructed to bring their
medication bottles to their enrollment visit, and study
personnel recorded all current medications. Medications
were categorized using Epocrates Rx (Epocrates Inc, San
Mateo, Calif). None of the data presented >5% missing
variables. Questionnaires were reported as missing if $30%
of the individual items were missing. Otherwise, the total
score was divided by the proportion answered to account
for missing data. The appropriate Institutional Review
Boards approved the protocol, and all participants provided
written informed consent for participation in the study.
Blood samples. Fasting blood samples were obtained
during the morning of the enrollment visit. Levels of
high-sensitivity C-reactive protein (hsCRP), interleukin-
6 (IL-6), and tumor necrosis factor-a (TNF-a) were
determined from plasma and serum samples. These bio-
markers were chosen because of their association with
disease severity in PAD.19-22 Levels of hsCRP were
measured using the Integra assay (Roche, Indianapolis,
Ind) or (owing to a change at the laboratory) the
Extended Range assay (Beckman Coulter Ireland Inc,
Galway, Ireland). Prior testing demonstrated high corre-
lation of these two methods.23 We used the Quantikine
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Minn) to determine the concentration of IL-6 and the
Human Serum Adipokine Panel B LINCOplex Kit (Linco
Research Inc, St. Charles, Mo) to measure TNF-a. Low-
density and high-density lipoprotein cholesterol levels were
measured from fasting venous blood samples at baseline.
Behavioral and lifestyle factors. A history of smoking
was determined by self-report questionnaire. Alcohol use
was evaluated with the validated Alcohol Use Disorders
Identiﬁcation Test Alcohol Consumption Questions
(AUDIT-C) questionnaire.24 To assess medication adher-
ence, participants were asked, “In the past month, how
often did you take your medications as the doctor pre-
scribed?” Possible responses were “all of the time (100%),”
“nearly all of the time (90%),” “most of the time (75%),”
“about half the time (50%),” or “less than half the time
(#50%).” We deﬁned medication nonadherence as taking
prescribed medications #75% of the time.25
To assess physical activity, the participants were asked,
“Which of the following statements best describes how
physically active you have been during the past month,
that is, done activities such as 15 to 20 minutes of brisk
walking, swimming, general conditioning, or recreational
sports?” Participants chose one of the following six cate-
gories: not at all active, a little active (1-2 times per
month), fairly active (3-4 times per month), quite active
(1-2 times per week), very active (3-4 times per week),
or extremely active ($5 times per week). Participants
who reported that they were not at all or a little active
were considered physically inactive. Self-report has been
shown to be a reliable, valid, and accurate method of
assessing physical activity.26,27
Mental health factors. Depressive symptoms were
assessed with the validated nine-item Patient Health
Questionnaire (PHQ-9).28 The PHQ-9, which provides a
dichotomous measure of depressive symptoms based on a
score of $10, has a sensitivity of 88% and a speciﬁcity of
88% for major depressive disorders29 and has been used for
diagnosis purposes in patients with PAD.15 Anxiety
symptoms were assessed by the Hospital Anxiety and
Depression Scale (HADS).30 The HADS questionnaire
score ranges from 0 to 21, with higher scores representing
higher levels of anxiety. A score of $8 on the anxiety
subscale has a sensitivity and speciﬁcity of w80% as a case
ﬁnder for anxiety disorders.31
Statistical analysis. Differences in baseline characteris-
tics by gender were evaluated with t-tests for continuous
variables and c2 tests for categoric variables (no variables
had >4% missing data). We log-transformed covariates
with severely right-skewed distributions (inﬂammatory
biomarkers). Logistic regression models were used to
calculate odds ratios (ORs) and conﬁdence intervals (CIs).
Variables included in the multivariate models were based
on an a priori determination of signiﬁcance at <.10 based
on univariate models, in addition to age and activity status.
To help interpret negative ﬁndings, CIs were assessed in
addition to P values for logistic regression estimates. A
wide CI generally fails to rule out substantial effects in atleast one direction for negative ﬁndings, whereas a narrow
CI increases the certainty about nonsigniﬁcant ﬁndings.32
Statistical analyses were performed using Stata/SE 12
software (StataCorp LP, College Station, Tex).
RESULTS
PAD was present in 21 women (11%) and 113 men
(13%). Women with PAD had a similar prevalence of hy-
pertension, diabetes mellitus, and history of MI compared
with women without PAD (Table I). There were no signif-
icant differences in the use of aspirin, angiotensin-
converting enzyme inhibitors, or statins between the two
groups. Women with and without PAD were equally likely
to be smokers, and their lipid proﬁles did not differ signif-
icantly. Women with PAD were signiﬁcantly more likely to
suffer from depression (P ¼ .01) or have a history of alco-
holism (P ¼ .01) compared with women without PAD.
Men with PAD, compared with men without PAD,
were more likely to have hypertension, diabetes mellitus,
a history of alcoholism, and past coronary revascularization
(Table II). Men with PAD were also more likely to have
a history of smoking and had lower levels of high-density
lipoprotein cholesterol and higher levels of inﬂammatory
biomarkers (hsCRP, IL-6, TNF-a, and ﬁbrinogen) com-
pared with men without PAD.
A univariate analysis demonstrated that diastolic blood
pressure (P ¼ .07), glucose (P ¼ .08), a history of alco-
holism (P ¼ .006), and depression (P ¼ .01) were associ-
ated with PAD. In a multivariate analysis, depressive
symptoms had the strongest relationship to PAD in women
(P ¼ .03; Table III).
A univariate analysis demonstrated that hypertension
(P ¼ .02), diabetes mellitus (P ¼ .01), hsCRP (P <
.0001), ﬁbrinogen (P < .0001), high-density lipoprotein
cholesterol (P ¼ .01), smoking (P ¼ .02), physical activity
(P ¼ .08), and depressive symptoms (P ¼ .09) were asso-
ciated with PAD in men. In the multivariate analysis
(Table IV), ﬁbrinogen (P ¼ .05) and a history of smoking
(P ¼ .03) remained independently associated with PAD
in men.
DISCUSSION
That traditional CVD risk factors are strongly associ-
ated with the development and progression of PAD is
well known; however, few studies have examined PAD
risk factors separately by gender. In our study, we found
traditional risk factors were similar in prevalence in women
with and without PAD, but these traditional risk factors
were more prevalent in men with PAD than in men
without PAD. This suggests that other risk factors might
contribute to PAD in women. In women, depression was
the strongest risk factor for PAD.
The Multi-Ethnic Study of Atherosclerosis (MESA) of
1932 participants free of four traditional CVD risk factors
(smoking, diabetes, hypertension, and dyslipidemia) found
there was still a signiﬁcant association between female
gender and lower ankle-brachial index.8 In a cohort of
>15,000 participants, women who had never smoked
Table I. Characteristics of women with and without peripheral arterial disease (PAD)
Characteristicsa Women with PAD (n ¼ 21) Women without PAD (n ¼ 163) P
Traditional risk factors
Age, years 67 6 12 64 6 11 .21
Caucasian 11 (52) 80 (49) .78
BMI, kg/m2 28 6 7 30 6 6 .39
Waist-to-hip ratio 0.886 0.06 0.88 60.07 .86
Comorbidities and cardiac disease severity
Hypertension 16 (76) 120 (74) .80
History of MI 11 (55) 72 (45) .38
Past coronary revascularization 9 (43) 72 (44) .89
LVEF, % 64 6 7 64 6 8 .93
CHF 5 (24) 28 (17) .46
Treadmill score, METs 6 6 3 7 6 3 .23
Diabetes mellitus 7 (33) 44 (27) .54
Arthritis 15 (71) 100 (62) .49
Systolic blood pressure, mm Hg 139 6 21 137 6 22 .82
Diastolic blood pressure, mm Hg 71 6 11 76 6 11 .07
Medications
Aspirin 13 (62) 115 (71) .42
ACE inhibitor 8 (38) 76 (47) .46
b-blocker 8 (38) 87 (53) .19
Statin 10 (48) 89 (55) .55
Antidepressant 5 (24) 40 (25) .94
Traditional risk factors, inﬂammation, and metabolic factors
History of smoking 12 (57) 90 (55) .87
Cholesterol, mg/dL
Total 196 6 52 191 6 48 .65
LDL 114 6 9 111 6 41 .78
HDL 53 6 17 53 6 17 .94
Hemoglobin A1c, % 6 6 1 6 6 1 .48
Glucose, mg/dL 132 6 55 116 6 36 .07
Log hsCRP, mg/L 0.7 61.3 1.1 6 1.3 .22
Log IL-6, pg/mL 1.0 6 0.6 0.9 6 0.8 .31
Log TNF-a, pg/mL 1.4 6 1.1 1.2 6 0.8 .52
Log ﬁbrinogen, mg/dL 6.0 6 0.2 6.0 6 0.2 .35
Psychosocial and behavioral risk factors
Depression by PHQ-9 score 10 (48) 37 (23) .01
Current PTSD 1 (5) 22 (14) .26
History of general anxiety disorder 5 (24) 30 (18) .55
Anxiety score 7 6 3 7 6 4 .88
Married 3 (14) 45 (28) .19
Poor social support 16 (76) 113 (69) .52
Physically active 14 (67) 86 (53) .24
Adherent to medication 17 (81) 139 (87) .41
History of alcoholism 3 (14) 8 (5) .01
Regular alcohol use 4 (19) 25 (16) .68
ACE, Angiotensin-converting enzyme; BMI, body mass index; CHF, congestive heart failure; HDL, high-density lipoprotein; hsCRP, high-sensitivity
C-reactive protein; IL-6, interleukin 6; LDL, low-density lipoprotein; LVEF, left ventricular ejection fraction; METS, metabolic equivalents; MI, myocardial
infarction; PHQ, Patient Health Questionnaire; PTSD, post-traumatic stress disorder; TNF-a, tumor necrosis factor-a.
aContinuous data are shown as mean 6 standard deviation and categoric data as number (%).
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never-smokers, even after adjustment for age, low-density
lipoprotein cholesterol, hypertension, and diabetes.33 In
our study, depression was more common in women with
PAD compared with those without PAD. It is possible
that women and men have a different set of risk factors
for PAD and that depression or other psychosocial factors
might be more important in women. These risk factors
are not commonly evaluated in PAD studies, and further
research is needed to better clarify these associations.
The reason for a very close relationship between
depression and PAD in women is therefore unclear. Priorresearch suggests that women with PAD aged <65 years
are particularly vulnerable to experiencing depressive symp-
toms.17 The authors postulated that this may be secondary
to differential social roles and demands women face, care
responsibilities for their families, combining work and
home responsibilities, lower income and job inequality, as
well as being a single parent.17 Women in their study
were not asked speciﬁcally why they were depressed.
Some other angles may be considered in terms of etio-
logic relevance. One is the association between depression
and chronic diseases. Huang et al34 recently assessed the
pooled risks of depression in elderly patients with chronic
Table II. Characteristics of men with or without peripheral arterial disease (PAD)
Characteristicsa Men with PAD (n ¼ 113) Men without PAD (n ¼ 727) P
Traditional risk factors
Age, years 68 6 10 67 6 11 .91
Caucasian 75 (66) 449 (62) .36
BMI, kg/m2 28 6 5 28 6 5 .99
Waist-to-hip ratio 0.98 6 0.06 0.97 6 0.07 .20
Comorbidities and cardiac disease severity
Hypertension 90 (80) 497 (69) .02
History of MI 68 (60) 396 (55) .28
Past coronary revascularization 81 (72) 440 (61) .03
LVEF, % 60 6 10 61 6 10 .43
CHF 38 (34) 108 (15) <.0001
Treadmill score, METs 6 6 3 8 6 3 .0003
Diabetes mellitus 40 (35) 174 (24) .01
Arthritis 64 (57) 377 (52) .53
Systolic blood pressure, mm Hg 134 6 23 132 6 20 .31
Diastolic blood pressure, mm Hg 73 6 13 75 6 11 .29
Medications
Aspirin 96 (85) 568 (78) .10
ACE inhibitor 68 (60) 372 (51) .07
b-blocker 74 (65) 424 (58) .15
Statin 82 (73) 476 (65) .14
Antidepressant 22 (19) 121 (17) .46
Traditional risk factors, inﬂammation and metabolic factors
History of smoking 92 (81) 515 (71) .02
Cholesterol, mg/dL
Total 171 6 39 176 6 41 .26
LDL 100 6 30 103 6 32 .27
HDL 41 6 12 45 6 13 .01
Hemoglobin A1c, % 6 6 1 6 6 1 .48
Glucose, mg/dL 132 6 55 116 6 36 .07
Log hsCRP, mg/L 1.161.3 0.6 6 1.3 .0005
Log IL-6, pg/mL 1.3 6 0.7 0.9 6 0.7 <.00001
Log TNF-a, pg/mL 1.4 6 0.9 1.2 6 0.9 .008
Log ﬁbrinogen, mg/dL 6.0 6 0.2 5.9 6 0.2 .0001
Psychosocial and behavioral risk factors
Depression by PHQ-9 score 27 (24) 125 (17) .09
Current PTSD 10 (9) 62 (9) .92
History of general anxiety disorder 12 (11) 60 (8) .41
Anxiety score 5 6 6 5 6 4 .22
Married 51 (45) 337 (47) .78
Poor social support 68 (60) 496 (68) .08
Physically active 67 (60) 482 (66) .17
Adherent to medication 106 (95) 670 (93) .45
History of alcoholism 26 (23) 96 (13) .02
Regular alcohol use 28 (25) 236 (33) .10
ACE, Angiotensin-converting enzyme; BMI, body mass index; CHF, congestive heart failure; HDL, high-density lipoprotein; hsCRP, high-sensitivity
C-reactive protein; LDL, low-density lipoprotein; IL-6, interleukin 6; LVEF, left ventricular ejection fraction; METS, metabolic equivalents; MI, myocardial
infarction; PHQ, Patient Health Questionnaire; PTSD, post-traumatic stress disorder; TNF-a, tumor necrosis factor-a.
aContinuous data are shown as mean 6 standard deviation and categoric data as number (%).
JOURNAL OF VASCULAR SURGERY
400 Grenon et al August 2014diseases. Their analysis demonstrated that several chronic
disorders increase the risk of depression; for example,
stroke (OR, 1.98; 95% CI, 1.33-2.62), poor hearing
(OR, 1.71; 95% CI, 1.28-2.27), poor vision (OR, 1.94;
95% CI, 1.68-2.25), arthritis (OR, 2.27; 95% CI, 1.35-
3.82), hypertension (OR, 1.25; 95% CI, 1.04-1.50), car-
diac disease (OR, 1.67; 95% CI, 1.37-2.04), chronic lung
disease (OR, 2.13; 95% CI, 1.23-3.71), diabetes (OR,
1.81; 95% CI, 1.29-2.54), gastrointestinal disease (OR,
1.95; 95% CI, 0.80-4.70), and kidney disease (OR, 2.22;
95% CI, 1.31-3.77). Interestingly, from the present study
and our previous work, we can state that a close associationexists between depression and PAD, one that appears even
tighter in females. Adjustment for chronic conditions did
not alter our conclusions with regards to the association
between depression and PAD, suggesting an independent
association between the two diseases.
We and others have demonstrated that depression is a
risk factor for PAD.12,35,36 In addition to increasing the
risk of PAD, depression also appears to impact the func-
tional status and symptoms of patients with PAD, leading
to more dramatic annual declines in functional perfor-
mance,13 reduced walking distance,14 and reduced quality
of life beneﬁt after revascularization.15 The ﬁndings from
Table III. Independent risk factors for peripheral arterial
disease (PAD) in women using a multivariate modela
Risk factors OR 95% CI P
Age 1.04 0.99-1.10 .10
Diastolic blood pressure 0.97 0.93-1.02 .30
Blood glucose 1.01 1.00-1.02 .05
Physically activity 1.21 0.88-1.66 .23
History of alcoholism 1.30 1.00-1.68 .05
Depression 3.26 1.09-9.77 .03
CI, Conﬁdence interval; OR, odds ratio.
aVariables included in the multivariate models were based on an a priori
determination of signiﬁcance at <.10 based on univariate models, in addi-
tion to age.
Table IV. Independent risk factors for peripheral arterial
disease (PAD) in men using a multivariate modela
Risk factors OR 95% CI P
Age 1.01 0.99-1.03 .33
Hypertension 1.54 0.92-2.57 .10
Diabetes mellitus 1.36 0.86-2.16 .19
hsCRP 1.14 0.86-1.50 .36
Fibrinogen 1.30 1.00-1.70 .05
HDL cholesterol 0.80 0.63-1.01 .07
History of smoking 1.46 1.05-2.04 .03
Physical activity 1.00 0.88-1.15 .92
Depression 1.43 0.84-2.43 .19
CI, Conﬁdence interval; HDL, high-density lipoprotein; hsCRP, high-
sensitivity C-reactive protein; OR, odds ratio.
aVariables included in the multivariate models were based on an a priori
determination of signiﬁcance at <.10 based on univariate models, in addi-
tion to age. Continuous predictors (log CRP, log ﬁbrinogen, and HDL)
were entered per standard deviation.
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ioral and psychosocial risk factors in the development of
CVDs. Although not speciﬁcally evaluated in patients
with PAD, social support has been linked to adverse cardio-
vascular outcomes in other populations.37 Patients at risk
or with an atherothrombotic disorder who lived alone
were at higher risk of cardiovascular death than those
who lived with someone.38 In a recent review, low “func-
tional support” increased cardiac and all-cause mortality.39
General stress, work-related stress, and the feeling of “lack
of control” are among other psychosocial risk factors now
recognized as potential risk factors for CVDs.40 Overall,
it is possible that psychosocial risk factors affect CVDs
and inﬂuence the development of PAD.
The direction of the association between depression
and PAD therefore remains poorly understood. From the
results of the present study, we can conclude that an asso-
ciation between these two diseases is present. It is quite
plausible that patients experiencing functional impairment
secondary to PAD develop depression that contributes to
worsening health behaviors and increased inﬂammation.
Findings from our previous study, however, also suggest
that patients with depressive symptoms are more likely to
experience PAD when followed up prospectively.12 Hence,
a few explanations are possible:
1. Depression in itself leads to an increase in modiﬁable
risk factors, such as smoking and physical inactivity,
and subsequently, to an increased risk of PAD,
2. Patients with PAD are more depressed because of
their disease and functional impairment,
3. These two hypotheses lead to a vicious circle tightly
linking depression, PAD, and unhealthy behaviors.
At the present time and based on the ﬁndings of this
study, these hypotheses remain speculative.
The ﬁndings of this study have important implications
for clinical practice. Depression may play an important role
in the pathophysiology of PAD. That depressive symptoms
could potentially not only affect the development of disease
but also hinder treatment beneﬁts and rehabilitation is also
possible. Although previous studies have demonstrated a
clear association between depression and CVD, whetherpharmacologic treatment of depression can improve car-
diovascular outcomes, particularly those related to PAD,
is still unclear. Future studies should focus on the effects
of treatment of depression on the progression and out-
comes of patients with PAD.
Our study ﬁndings must be interpreted in light of
several limitations. The ﬁrst major limitation is that this
was a secondary analysis with a limited number of patients
(especially women) and, subsequently, limited power to
detect differences. The small sample size and low propor-
tion of women (<20%) limits our ability to detect sex-
speciﬁc differences. It is also possible that a type II statistical
error was introduced in our sample when we assessed the as-
sociation between men and PAD, limiting our ability to
detect a signiﬁcant difference. Because of these limitations,
the study should be considered as a pilot and hypothesis-
generating study. Furthermore, because the aim of the
Heart and Soul Study was to measure risks of development
of cardiac diseases, it is possible that selection bias was intro-
duced in the study, further limiting interpretation of results
in the context of PAD.
Second, because the primary objective was to assess the
effect of psychologic factors in patients with CAD, several
PAD measures are missing, including the ankle-brachial in-
dex. This further limits the inferences that can be made
from our results and the assessment of PAD-speciﬁc mea-
sures. In addition, the Heart and Soul Study includes
mostly urban men with existing heart disease, which may
limit the generalizability of our results.
CONCLUSIONS
In this study of outpatients with stable CAD, tradi-
tional CVD risk factors were associated with PAD in
men. Depression was signiﬁcantly more common in
women with PAD compared with those without PAD.
Given the heavy burden of PAD in women, our ﬁndings
highlight the importance of continuing investigations in
the ﬁeld of gender differences in PAD, with a particular
focus on mental health. Depression, particularly in women,
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with regards to its association with CVDs.AUTHOR CONTRIBUTIONS
Conception and design: MG, BC, JH
Analysis and interpretation: MG, BC, KS, MW, JH, EV
Data collection: MW
Writing the article: MG
Critical revision of the article: BC, KS, MW, JH, EV
Final approval of the article: MG, BC, KS, MW, JH, EV
Statistical analysis: MG, EV
Obtained funding: MG, MW
Overall responsibility: MGREFERENCES
1. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO,
McDermott MM, et al. Comparison of global estimates of prevalence
and risk factors for peripheral artery disease in 2000 and 2010: a sys-
tematic review and analysis. Lancet 2013;382:1329-40.
2. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O,
Andersson B, Persson E, et al. A population-based study of peripheral
arterial disease prevalence with special focus on critical limb ischemia
and sex differences. J Vasc Surg 2007;45:1185-91.
3. Moussa ID, Jaff MR, Mehran R, Gray W, Dangas G, Lazic Z, et al.
Prevalence and prediction of previously unrecognized peripheral arte-
rial disease in patients with coronary artery disease: the Peripheral
Arterial Disease in Interventional Patients Study. Catheter Cardiovasc
Interv 2009;73:719-24.
4. Hirsch AT, Allison MA, Gomes AS, Corriere MA, Duval S,
Ershow AG, et al. American Heart Association Council on Peripheral
Vascular Disease; Council on Cardiovascular Nursing; Council on
Cardiovascular Radiology and Intervention; Council on Cardiovascular
Surgery and Anesthesia; Council on Clinical Cardiology; Council on
Epidemiology and Prevention. A call to action: women and peripheral
artery disease: a scientiﬁc statement from the American Heart Associ-
ation. Circulation 2012;125:1449-72.
5. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ,
et al. Results of PREVENT III: a multicenter, randomized trial of
edifoligide for the prevention of vein graft failure in lower extremity
bypass surgery. J Vasc Surg 2006;43:742-51; discussion: 751.
6. Hoel AW, Kayssi A, Brahmanandam S, Belkin M, Conte MS,
Nguyen LL. Under-representation of women and ethnic minorities in
vascular surgery randomized controlled trials. J Vasc Surg 2009;50:
349-54.
7. McDermott MM, Liu K, Criqui MH, Ruth K, Goff D, Saad MF, et al.
Ankle-brachial index and subclinical cardiac and carotid disease: the
multi-ethnic study of atherosclerosis. Am J Epidemiol 2005;162:33-41.
8. Aboyans V, McClelland RL, Allison MA, McDermott MM,
Blumenthal RS, Macura K, et al. Lower extremity peripheral artery
disease in the absence of traditional risk factors. The Multi-Ethnic
Study of Atherosclerosis. Atherosclerosis 2011;214:169-73.
9. Ferrari AJ, Charlson FJ, Norman RE, Flaxman AD, Patten SB, Vos T,
et al. The epidemiological modelling of major depressive disorder:
application for the global burden of disease study 2010. PloS ONE
2013;8:e69637.
10. Weissman MM, Klerman GL. Sex differences and the epidemiology of
depression. Arch Gen Psychiatry 1977;34:98-111.
11. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S,
Hwu HG, et al. Cross-national epidemiology of major depression and
bipolar disorder. JAMA 1996;276:293-9.
12. Grenon SM, Hiramoto J, Smolderen KG, Vittinghoff E, Whooley MA,
Cohen BE. Association between depression and peripheral artery dis-
ease: insights from the heart and soul study. J Am Heart Assoc 2012;1:
e002667.13. Ruo B, Liu K, Tian L, Tan J, Ferrucci L, Guralnik JM, et al. Persistent
depressive symptoms and functional decline among patients with pe-
ripheral arterial disease. Psychosom Med 2007;69:415-24.
14. Smolderen KG, Aquarius AE, de Vries J, Smith OR, Hamming JF,
Denollet J. Depressive symptoms in peripheral arterial disease: a follow-
up study on prevalence, stability, and risk factors. J Affect Disord
2008;110:27-35.
15. Smolderen KG, Saﬂey DM, House JA, Spertus JA, Marso SP. Percu-
taneous transluminal angioplasty: association between depressive
symptoms and diminished health status beneﬁts. Vasc Med 2011;16:
260-6.
16. Cherr GS, Zimmerman PM, Wang J, Dosluoglu HH. Patients with
depression are at increased risk for secondary cardiovascular events after
lower extremity revascularization. J Gen Intern Med 2008;23:629-34.
17. Smolderen KG, Spertus JA, Vriens PW, Kranendonk S, Nooren M,
Denollet J. Younger women with symptomatic peripheral arterial dis-
ease are at increased risk of depressive symptoms. J Vasc Surg 2010;52:
637-44.
18. Whooley MA, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney RM,
et al. Depressive symptoms, health behaviors, and risk of cardiovascular
events in patients with coronary heart disease. JAMA 2008;300:
2379-88.
19. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH.
Plasma concentration of C-reactive protein and risk of developing pe-
ripheral vascular disease. Circulation 1998;97:425-8.
20. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic
atherosclerosis: a comparison of C-reactive protein, ﬁbrinogen, ho-
mocysteine, lipoprotein(a), and standard cholesterol screening as pre-
dictors of peripheral arterial disease. JAMA 2001;285:2481-5.
21. Beckman JA, Preis O, Ridker PM, Gerhard-Herman M. Comparison of
usefulness of inﬂammatory markers in patients with versus without
peripheral arterial disease in predicting adverse cardiovascular outcomes
(myocardial infarction, stroke, and death). Am J Cardiol 2005;96:
1374-8.
22. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG.
C-reactive protein, interleukin-6, and soluble adhesion molecules as
predictors of progressive peripheral atherosclerosis in the general
population: Edinburgh Artery Study. Circulation 2005;112:976-83.
23. Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S.
Depression and inﬂammation in patients with coronary heart disease:
ﬁndings from the Heart and Soul Study. Biol Psychiatry 2007;62:
314-20.
24. Dawson DA, Grant BF, Stinson FS. The AUDIT-C: screening for
alcohol use disorders and risk drinking in the presence of other psy-
chiatric disorders. Comp Psychiatry 2005;46:405-16.
25. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adher-
ence and cardiovascular events in patients with stable coronary heart
disease: the heart and soul study. Arch Intern Med 2007;167:
1798-803.
26. Kurtze N, Rangul V, Hustvedt BE, Flanders WD. Reliability and val-
idity of self-reported physical activity in the Nord-Trondelag Health
Study: HUNT 1. Scand J Public Health 2008;36:52-61.
27. Ainsworth BE, Jacobs DR Jr, Leon AS. Validity and reliability of self-
reported physical activity status: the Lipid Research Clinics question-
naire. Med Sci Sports Exerc 1993;25:92-8.
28. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-
report version of PRIME-MD: the PHQ primary care study. Primary
Care Evaluation of Mental Disorders. Patient Health Questionnaire.
JAMA 1999;282:1737-44.
29. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief
depression severity measure. J Gen Intern Med 2001;16:606-13.
30. Zigmond AS, Snaith RP. The hospital anxiety and depression scale.
Acta Psychiatr Scand 1983;67:361-70.
31. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the
Hospital Anxiety and Depression Scale. An updated literature review.
J Psychosom Res 2002;52:69-77.
32. Hoenig JM, Heisey DM. The abuse of power: the pervasive fallacy of
power calculations for data analysis. Am Stat 2001;55:19-24.
33. Zheng ZJ, Rosamond WD, Chambless LE, Nieto FJ, Barnes RW,
Hutchinson RG, et al. Lower extremity arterial disease assessed by
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 2 Grenon et al 403ankle-brachial index in a middle-aged population of African Americans
and whites: the Atherosclerosis Risk in Communities (ARIC) Study.
Am J Prev Med 2005;29:42-9.
34. Huang CQ, Dong BR, Lu ZC, Yue JR, Liu QX. Chronic diseases and
risk for depression in old age: a meta-analysis of published literature.
Ageing Res Rev 2010;9:131-41.
35. Wattanakit K, Williams JE, Schreiner PJ, Hirsch AT, Folsom AR. As-
sociation of anger proneness, depression and low social support with
peripheral arterial disease: the Atherosclerosis Risk in Communities
Study. Vasc Med 2005;10:199-206.
36. Arseven A, Guralnik JM, O’Brien E, Liu K, McDermott MM. Pe-
ripheral arterial disease and depressed mood in older men and women.
Vasc Med 2001;6:229-34.
37. Uchino BN, Bowen K, Carlisle M, Birmingham W. Psychological
pathways linking social support to health outcomes: a visit with the“ghosts” of research past, present, and future. Soc Sci Med 2012;74:
949-57.
38. Udell JA, Steg PG, Scirica BM, Smith SC Jr, Ohman EM, Eagle KA,
et al. REduction of Atherothrombosis for Continued Health (REACH)
Registry Investigators. Living alone and cardiovascular risk in out-
patients at risk of or with atherothrombosis. Arch Intern Med
2012;172:1086-95.
39. Barth J, Schneider S, von Kanel R. Lack of social support in the eti-
ology and the prognosis of coronary heart disease: a systematic review
and meta-analysis. Psychosom Med 2010;72:229-38.
40. Neylon A, Canniffe C, Anand S, Kreatsoulas C, Blake GJ, Sugrue D,
et al. A global perspective on psychosocial risk factors for cardiovascular
disease. Prog Cardiovasc Dis 2013;55:574-81.
Submitted Nov 25, 2013; accepted Feb 7, 2014.
